![](/coreweb/template1/pix/main_left_bg.gif) |
![](/coreweb/template1/pix/pixel.gif) |
GEO help: Mouse over screen elements for information. |
|
Status |
Public on Aug 28, 2018 |
Title |
TCPOBOP-induced hepatomegaly & hepatocyte proliferation is attenuated by combined disruption of MET & EGFR signaling in mice |
Organism |
Mus musculus |
Experiment type |
Expression profiling by array
|
Summary |
TCPOBOP (1,4-Bis [2-(3,5-Dichloropyridyloxy)] benzene) is a constitutive androstane receptor (CAR) agonist that induces robust hepatocyte proliferation and hepatomegaly without any liver injury or tissue loss. TCPOBOP-induced direct hyperplasia has been considered to be CAR-dependent with no evidence of involvement of cytokines or growth factor signaling. Receptor tyrosine kinases (RTKs), MET and EGFR, are known to play a critical role in liver regeneration after partial hepatectomy, but their role in TCPOBOP-induced direct hyperplasia, not yet explored, is investigated in the current study. Disruption of the RTK-mediated signaling was achieved utilizing MET KO mice along with Canertinib treatment for EGFR inhibition. Combined elimination of MET and EGFR signaling [MET KO + EGFRi], but not individual disruption, dramatically reduced TCPOBOP-induced hepatomegaly and hepatocyte proliferation. TCPOBOP-driven CAR activation was not altered in [MET KO + EGFRi] mice, as measured by nuclear CAR translocation and analysis of typical CAR target genes. However, TCPOBOP induced cell cycle activation was impaired in [MET KO + EGFRi] mice due to defective induction of cyclins, which regulate cell cycle initiation and progression. TCPOBOP-driven induction of FOXM1, a key transcriptional regulator of cell cycle progression during TCPOBOP-mediated hepatocyte proliferation, was greatly attenuated in [MET KO + EGFRi] mice. Interestingly, TCPOBOP treatment caused transient decline in HNF4α expression concomitant to proliferative response; this was not seen in [MET KO + EGFRi] mice. Transcriptomic profiling revealed vast majority (~40%) of TCPOBOP-dependent genes mainly related to proliferative response, but not to drug metabolism, were differentially expressed in [MET KO + EGFRi] mice. Conclusion: Taken together, combined disruption of EGFR and MET signaling lead to dramatic impairment of TCPOBOP-induced proliferative response without altering CAR activation. We used microarrays to detail the global programme of gene expression in [METKO + EGFRi] mice liver following TCPOBOP treatment
|
|
|
Overall design |
Systemic inhibition MET-EGFR signaling pathway in mice was carried out by using a tamoxifen inducible system to systemically delete MET and EGFR was inhibited by using Canertinib added to diet. TCPOBOP was administered at Day 0 and liver tissue harvested at defined time points and gene arrays carried out.
|
|
|
Contributor(s) |
Bhushan B, Michalopoulos GK |
Citation(s) |
29888801 |
Submission date |
Feb 15, 2018 |
Last update date |
Feb 11, 2019 |
Contact name |
George K Michalopoulos |
E-mail(s) |
michalopoulosgk@upmc.edu
|
Organization name |
University of Pittsburgh
|
Street address |
411 SBST, 200 Lothrop Street
|
City |
Pittsburgh |
State/province |
Pennsylvania |
ZIP/Postal code |
15261 |
Country |
USA |
|
|
Platforms (1) |
GPL1261 |
[Mouse430_2] Affymetrix Mouse Genome 430 2.0 Array |
|
Samples (8)
|
GSM3014594 |
Liver tissue from corn oil treated MET flox mice at Day 0 after TCPOBOP administration |
GSM3014595 |
Liver tissue from Canertinib treated MET KO mice at Day 0 after TCPOBOP administration |
GSM3014596 |
Liver tissue from corn oil treated MET flox mice at Day 1 after TCPOBOP administration |
GSM3014597 |
Liver tissue from Canertinib treated MET KO mice at Day 1 after TCPOBOP administration |
GSM3014598 |
Liver tissue from corn oil treated MET flox mice at Day 2 after TCPOBOP administration |
GSM3014599 |
Liver tissue from Canertinib treated MET KO mice at Day 2 after TCPOBOP administration |
GSM3014600 |
Liver tissue from corn oil treated MET flox mice at Day 5 after TCPOBOP administration |
GSM3014601 |
Liver tissue from Canertinib treated MET KO mice at Day 5 after TCPOBOP administration |
|
Relations |
BioProject |
PRJNA434289 |
Supplementary file |
Size |
Download |
File type/resource |
GSE110695_RAW.tar |
33.1 Mb |
(http)(custom) |
TAR (of CEL) |
Processed data included within Sample table |
|
|
|
|
![](/coreweb/template1/pix/main_right_bg.gif) |